Globus Medical

Globus Medical

GMED · NYSE · Healthcare / Medical Devices

72.14USD-0.16 (-0.22%)

Price History

Full chart

Market Stats

Previous Close72.30
Open72.75
Day Range71.72 – 73.45
52-Week Range70.40 – 101.40
Volume1.55M
Market Cap10.93B
P/E (TTM)20.06
Forward P/E16.29
EPS4.06
Dividend Yield0.00%
Beta0.95
50-Day Avg77.46
200-Day Avg83.33

About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Keith W. Pfeil
  • Employees6.00K
  • Headquarters2560 General Armistead Avenue, Audubon, PA, United States, 19403-5214, USA
  • Websitehttps://www.globusmedical.com

Leadership

  • Mr. David C. PaulCo-Founder & Executive Chairman · b. 1967
  • Mr. Keith W. PfeilCEO, President & Director · b. 1979
  • Mr. Kyle R. KlinSenior VP & CFO · b. 1986
  • Ms. Kelly G. Huller Esq.Executive VP, General Counsel & Corporate Secretary · b. 1972
  • Mr. Brian J. KearnsSenior Vice President of Business Development & Investor Relations · b. 1967

Financials

Income Statement

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue254.34M288.19M331.48M385.99M434.46M474.37M544.75M563.99M635.98M712.97M785.37M789.04M958.10M1.02B1.57B2.52B2.94B
Growth (%)-+13.31%+15.02%+16.45%+12.56%+9.19%+14.84%+3.53%+12.76%+12.11%+10.15%+0.47%+21.43%+6.76%+53.34%+60.62%+16.65%
Cost of Revenue41.61M53.83M68.80M75.20M100.34M110.77M132.33M134.71M150.45M159.41M179.97M217.46M239.22M263.73M548.17M1.04B957.80M
Gross Profit212.74M234.37M262.68M310.80M334.12M363.60M412.42M429.29M485.52M553.56M605.39M571.58M718.88M759.12M1.02B1.48B1.98B
Gross Margin83.64%81.32%79.25%80.52%76.90%76.65%75.71%76.12%76.34%77.64%77.08%72.44%75.03%74.22%65.05%58.90%67.41%
Operating Expense130.83M146.69M165.32M196.00M232.44M225.24M240.20M275.15M323.68M384.23M433.40M460.15M546.93M531.17M887.16M1.32B1.50B
Operating Income81.91M87.69M97.36M114.79M101.67M138.36M172.22M154.14M161.84M169.32M171.99M111.43M171.95M227.95M133.14M165.99M479.80M
Operating Margin32.20%30.43%29.37%29.74%23.40%29.17%31.61%27.33%25.45%23.75%21.90%14.12%17.95%22.29%8.49%6.59%16.33%
EBITDA97.30M105.67M115.78M132.68M120.93M159.59M195.59M192.99M205.39M218.51M229.49M178.35M264.73M304.50M346.58M473.73M886.74M
EBITDA Margin38.25%36.67%34.93%34.37%27.83%33.64%35.90%34.22%32.29%30.65%29.22%22.60%27.63%29.77%22.10%18.80%30.17%
Net Income48.73M54.46M60.78M73.83M68.61M92.48M112.78M104.34M107.35M156.47M155.21M102.28M149.19M190.17M122.87M102.98M537.90M
Net Income Margin19.16%18.90%18.34%19.13%15.79%19.50%20.70%18.50%16.88%21.95%19.76%12.96%15.57%18.59%7.83%4.09%18.30%
R&D20.52M21.31M23.46M27.93M26.87M31.17M36.31M44.53M43.68M55.50M60.07M84.52M97.35M73.02M124.01M163.75M185.00M
R&D as % of Total Revenue8.07%7.39%7.08%7.23%6.18%6.57%6.67%7.90%6.87%7.78%7.65%10.71%10.16%7.14%7.91%6.50%6.29%
Interest Expense00000805.00K1.30M3.06M6.61M13.28M17.41M13.95M9.30M14.23M20.13M4.19M-
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.17%0.24%0.54%1.04%1.86%2.22%1.77%0.97%1.39%1.28%0.17%-

Balance Sheet

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--266.57M329.39M447.13M566.30M703.55M834.10M927.64M1.08B1.30B1.53B1.68B1.96B2.08B5.09B5.25B5.30B
Total Liabilities--38.38M46.91M60.63M93.94M118.09M118.78M95.56M110.72M115.15M129.63M173.19M215.88M229.75M1.09B1.07B729.51M
Total Equity--228.19M282.48M386.50M472.36M585.45M715.32M832.08M967.78M1.19B1.40B1.51B1.74B1.85B4.00B4.18B4.57B
Cash--111.70M142.67M212.40M89.96M82.27M60.15M66.95M118.82M139.75M195.72M239.40M193.07M150.47M467.29M784.44M526.16M
Total Debt--5.25M--------2.48M4.80M5.05M6.01M520.40M537.19M118.66M
Net Debt---106.45M-142.67M-212.40M-89.96M-82.27M-60.15M-66.95M-118.82M-139.65M-195.72M-239.40M-193.07M-144.46M53.11M-247.25M-407.50M

Cash Flow

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow32.08M71.29M76.41M76.52M93.47M79.17M121.96M171.89M159.53M181.64M171.97M198.79M276.27M178.47M243.50M520.64M753.45M
Investing Cash Flow-27.70M-12.00M-29.99M-30.71M-227.15M-100.00M-150.55M-99.55M-111.28M-193.03M-140.28M-117.32M-375.94M-110.36M302.97M-176.05M-355.01M
Financing Cash Flow1.49M1.77M-14.73M24.02M11.01M12.95M6.33M2.04M1.63M32.57M24.44M-38.66M54.15M-109.96M-231.82M-27.70M-679.16M
Capital Expenditure25.96M12.30M22.49M24.68M23.68M24.75M50.76M40.91M51.30M59.70M70.75M63.66M56.90M74.05M78.27M115.43M164.68M
Free Cash Flow6.12M58.98M53.92M51.84M69.79M54.42M71.20M130.98M108.23M121.95M101.22M135.13M219.38M104.42M165.22M405.21M588.77M
Dividends Paid---000000--------
FCF to OCF19.07%82.74%70.57%67.74%74.67%68.73%58.38%76.20%67.84%67.13%58.86%67.98%79.41%58.51%67.85%77.83%78.14%
Dividend Paid to FCF---0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateAug 29, 2012Nov 1, 2012Feb 27, 2013May 2, 2013Aug 1, 2013Oct 30, 2013Feb 26, 2014Apr 29, 2014Aug 5, 2014Oct 30, 2014Feb 25, 2015May 5, 2015Jul 30, 2015Nov 3, 2015Feb 24, 2016May 3, 2016Jul 26, 2016Nov 8, 2016Feb 27, 2017May 3, 2017Aug 2, 2017Nov 8, 2017Feb 21, 2018May 2, 2018Aug 1, 2018Nov 8, 2018Feb 21, 2019May 2, 2019Aug 1, 2019Nov 6, 2019Feb 20, 2020May 7, 2020Aug 5, 2020Oct 28, 2020Feb 17, 2021May 4, 2021Aug 4, 2021Nov 4, 2021Feb 17, 2022May 10, 2022Aug 4, 2022Nov 8, 2022Feb 21, 2023May 4, 2023Aug 3, 2023Nov 7, 2023Feb 20, 2024May 7, 2024Aug 6, 2024Nov 5, 2024Feb 18, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 25, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate-0.190.190.200.200.190.220.220.230.210.250.240.250.250.300.290.290.280.330.300.300.300.350.360.350.320.390.410.410.420.520.38-0.110.310.510.370.440.450.470.470.530.520.560.510.590.570.610.570.680.650.750.750.760.781.150.921.121.20
EPS Actual0.250.180.220.210.210.220.250.240.230.240.300.260.250.280.320.300.290.290.310.300.320.300.380.410.440.390.430.360.410.430.490.290.070.490.580.490.560.500.490.420.560.500.590.530.630.570.600.720.750.830.840.680.861.181.281.121.341.23
Surprise--5.26%15.79%5.00%5.00%15.79%13.64%9.09%0.00%14.29%20.00%8.33%0.00%12.00%6.67%3.45%0.00%3.57%-6.06%0.00%6.67%0.00%8.57%13.89%25.71%21.88%10.26%-12.20%0.00%2.38%-5.77%-23.68%163.64%58.06%13.73%32.43%27.27%11.11%4.26%-10.64%5.66%-3.85%5.36%3.92%6.78%0.00%-1.64%26.32%10.29%27.69%12.21%-9.33%13.16%51.28%10.96%21.74%19.64%2.50%
Timing-After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap10.93B
Enterprise Value11.21B
Trailing P/E20.06
Forward P/E16.29
PEG Ratio1.49
Price / Sales3.48
Price / Book2.45
EPS4.06
Book Value35.52
Revenue (TTM)3.14B
Gross Profit (TTM)2.17B
EBITDA1.01B
Profit Margin17.03%
Operating Margin24.76%
Return on Equity11.81%
Return on Assets8.74%
Shares Outstanding111.83M
Shares Float110.92M
Beta0.95
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 14 analystsTarget 100.92
  • Strong Buy
    7
  • Buy
    3
  • Hold
    4

Ownership Breakdown

Institutions
95.34%
Insiders
0.61%
Retail / Other
4.05%

Top Institutional Holders

  • BlackRock Inc
    10.81M8.05%
  • Jupiter Topco LLC
    8.20M6.11%
  • Vanguard Capital Management, LLC
    5.11M3.80%
  • Vanguard Portfolio Management, LLC
    4.99M3.72%
  • Amvescap Plc.
    4.31M3.21%
  • Kayne Anderson Rudnick Investment Management LLC
    4.28M3.19%
  • State Street Corp
    3.71M2.77%
  • OZ Management LLC
    3.00M2.23%
  • JPMorgan Chase & Co
    2.74M2.04%
  • BMO Capital Markets Corp.
    2.43M1.81%
  • Bank of Montreal
    2.43M1.81%
  • AllianceBernstein L.P.
    2.38M1.77%
  • Dimensional Fund Advisors, Inc.
    2.37M1.76%
  • Geode Capital Management, LLC
    2.15M1.60%
  • The Goldman Sachs Group Inc
    1.78M1.33%
  • Arrowstreet Capital Limited Partnership
    1.72M1.28%

Top Fund Holders

  • iShares Core S&P Mid-Cap ETF
    4.02M2.99%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.60M2.68%
  • Vanguard Small Cap Index
    2.53M1.89%
  • Janus Henderson Enterprise D
    2.31M1.72%